术前肌钙蛋白水平是否影响冠状动脉旁路移植术后的结局?
本研究纳入2002至2016年在本机构接受紧急或急诊单纯冠状动脉旁路移植术(CABG)且有术前肌钙蛋白测定的1,272例患者,评估术前峰值肌钙蛋白对术后并发症与死亡的影响。结果显示,术前肌钙蛋白阳性者手术死亡率、主要并发症和远期死亡率均更高,但风险校正后阳性肌钙蛋白与手术死亡率无独立关联(比值比2.61,p=0.053),峰值肌钙蛋白水平在任何时间点均不能独立预测死亡。
要点
- 术前肌钙蛋白阳性者手术死亡率3.7%对1.1%(p=0.009),主要并发症11.7%对3.9%(p<0.001)。
- 风险校正后,阳性肌钙蛋白与手术死亡率无独立关联(比值比2.61,p=0.053)。
- 校正与未校正分析均显示,术前峰值肌钙蛋白水平不能独立预测任何时间点的死亡(所有比值比1.0,p>0.05)。
核心结论
- 术前肌钙蛋白阳性与CABG术后更差的结局相关,但风险校正消除了该生物标志物的大部分短期预测价值。
- 峰值肌钙蛋白水平不影响CABG术后结局,在使用美国胸外科医师学会(STS)预测模型时对事件的预测能力差。
研究设计与样本
- 回顾性分析2002至2016年在本机构接受紧急或急诊单纯CABG且有术前肌钙蛋白测定的1,272例患者。
- 采用逻辑回归评估峰值肌钙蛋白水平对并发症与死亡的風險校正效应,并用Kaplan-Meier法和Cox比例风险模型进行远期生存分析。
主要发现
- 术前肌钙蛋白阳性者835例(65.6%),该组峰值肌钙蛋白中位数3.2 ng/mL(四分位距0.6至11.9 ng/mL),从峰值肌钙蛋白到手术的中位时间3天(四分位距1至4天)。
- 肌钙蛋白阳性与更多显著合并症和更广泛的冠状动脉病变相关。
- 肌钙蛋白阳性组手术死亡率3.7%对1.1%(p=0.009)、主要并发症11.7%对3.9%(p<0.001)、远期死亡率(中位生存12.5年对13.6年,p=0.01)均升高。
- 风险校正后,阳性肌钙蛋白与手术死亡率升高无独立关联(比值比2.61,p=0.053)。
- 校正与未校正分析均显示,术前峰值肌钙蛋白水平不能独立预测任何时间点的死亡(所有比值比1.0,p>0.05)。
临床怎么用
- 作者认为术前肌钙蛋白阳性与CABG术后更差结局相关,但风险校正后其短期预测价值大部分消失。
- 作者认为峰值肌钙蛋白水平不影响CABG术后结局,在使用美国胸外科医师学会(STS)预测模型时对事件的预测能力差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As a marker of myocardial injury, troponin level correlates with adverse outcomes after myocardial infarction (MI). We hypothesized that patients with a higher preoperative troponin level would have increased morbidity and mortality after coronary artery bypass grafting (CABG). METHODS: Preoperative troponin measurements were available for 1,272 patients who underwent urgent or emergent isolated CABG at our institution from 2002 to 2016. Logistic regression assessed the risk-adjusted effect of peak troponin level on morbidity and mortality. Long-term survival analysis was performed with Kaplan-Meier and Cox proportional hazards models. RESULTS: Preoperative troponin was positive in 835 patients (65.6%). The median peak troponin for this group was 3.2 ng/mL (interquartile range, 0.6 to 11.9 ng/mL), with a median time from peak troponin to the operation of 3 days (interquartile range, 1 to 4 days). Positive troponin was associated with more significant comorbid conditions and more extensive coronary artery disease. Operative mortality (3.7% versus 1.1%, p = 0.009), major morbidity (11.7% versus 3.9%, p < 0.001), and long-term mortality (median survival 12.5 years versus 13.6 years, p = 0.01) were increased in the positive troponin group. After risk adjustment, positive troponin was not independently associated with increased operative mortality (odds ratio, 2.61; p = 0.053). Adjusted and unadjusted analysis showed the peak preoperative troponin level did not independently predict death at any time point (all odds ratios, 1.0; p > 0.05). CONCLUSIONS: A positive preoperative troponin correlates with worse outcomes after CABG, but risk adjustment eliminates much of the short-term predictive value of this biomarker. Peak troponin level does not influence outcomes after CABG and is a poor predictor of events when The Society of Thoracic Surgeons predictive models are used.
引用
- Beller JP, Hawkins RB, Mehaffey JH, et al. Does Preoperative Troponin Level Impact Outcomes After Coronary Artery Bypass Grafting? Ann Thorac Surg. 2018. PMID: 29526501. doi:10.1016/j.athoracsur.2018.01.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。